Dual role of TNF‐α in NK / LAK cell‐mediated lysis of chronically HIV‐infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell‐mediated lysis
暂无分享,去创建一个
A. Lazzarin | P. Biswas | G. Poli | C. Fortis | L. Soldini | B. Mantelli | F. Delfanti | A. Careddu | Fabrizio Veglia | Michelangelo Murone
[1] C. Bovolenta,et al. A Selective Defect of IFN-γ- But Not of IFN-α-Induced JAK/STAT Pathway in a Subset of U937 Clones Prevents the Antiretroviral Effect of IFN-γ Against HIV-1 , 1999, The Journal of Immunology.
[2] J. Gariépy,et al. I Mhc Nk Cells Can Recognize Different Forms of Class , 2022 .
[3] Anthony S. Fauci,et al. Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines , 1998, The Journal of experimental medicine.
[4] A. Fauci,et al. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. , 1998, The Journal of clinical investigation.
[5] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[7] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[8] J Leibowitch,et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.
[9] M. Mengozzi,et al. Role of proinflammatory cytokines and β‐chemokines in controlling HIV replication , 1997, Journal of leukocyte biology.
[10] E. Podack,et al. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. , 1996, Journal of immunology.
[11] L. Lanier,et al. Inhibitory MHC class I receptors on NK cells and T cells. , 1996, Immunology today.
[12] Ali Ahmad,et al. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals , 1996, AIDS.
[13] J V Giorgi,et al. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[14] H. Ullum,et al. Defective natural immunity: an early manifestation of human immunodeficiency virus infection , 1995, The Journal of experimental medicine.
[15] L. Chieco‐Bianchi,et al. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. , 1995, Blood.
[16] J. Metcalf,et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. , 1995, The New England journal of medicine.
[17] Eric O Long,et al. Peptide specificity in the recognition of MHC class I by natural killer cell clones , 1995, Science.
[18] A. Fauci,et al. A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells , 1994, The Journal of experimental medicine.
[19] A. Fauci,et al. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? , 1994, Journal of virology.
[20] D. Goletti,et al. Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions. , 1994, Clinical immunology and immunopathology.
[21] L. Moretta,et al. CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV‐1‐infected target cells , 1994, European journal of immunology.
[22] S. Sambhara,et al. Effect of class I MHC binding peptides on recognition by natural killer cells. , 1992, Journal of immunology.
[23] J. Justement,et al. Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells , 1992, The Journal of experimental medicine.
[24] P. Cresswell,et al. Peptide-induced modulation of target cell sensitivity to natural killing. , 1992, Journal of immunology.
[25] R. Giorda,et al. Mouse NKR-P1. A family of genes selectively coexpressed in adherent lymphokine-activated killer cells. , 1991, Journal of immunology.
[26] J. Hoxie,et al. Natural killer cell‐mediated lysis of T cell lines chronically infected with HIV‐1 , 1990, Clinical and experimental immunology.
[27] P. Duerksen-Hughes,et al. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. , 1989, Journal of immunology.
[28] G. Soma,et al. Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication , 1989, Journal of virology.
[29] A. Fauci,et al. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. , 1989, Science.
[30] C. Rinaldo,et al. Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus , 1989, Journal of clinical microbiology.
[31] A. Dalgleish,et al. Infection of B lymphocytes by the human immunodeficiency virus and their susceptibility to cytotoxic cells , 1988, European journal of immunology.
[32] J. Justement,et al. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. , 1988, Journal of immunology.
[33] D. Stites,et al. In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. , 1988, Journal of immunology.
[34] M. Moroni,et al. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. , 1985, Clinical and experimental immunology.
[35] C. Bovolenta,et al. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. , 1999, Journal of immunology.
[36] R. Biassoni,et al. Receptors for HLA class-I molecules in human natural killer cells. , 1996, Annual review of immunology.
[37] D. Raulet,et al. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. , 1995, Immunity.
[38] M. Farrar,et al. The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.
[39] J. Justement,et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Ljunggren,et al. In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.
[41] G. Wong,et al. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons , 1986, Nature.